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ABSTRACT
A complication in the analysis of the role of ICP34.5 gene in the herpes simplex virus type-1 (HSV-1) 
lifecycle is the presence of overlapping antisense gene, open reading frame P (ORF P), which is also 
deleted in HSV-1 ICP34.5 negative mutants. A HSV-1 wild type strain (17+) ICP34.5/ORF P deletion 
mutant (1716) is totally avirulent in animal models and impaired in a number of in vitro functions: 
replication in 3T6 cells; and replication and shutoff of cellular protein synthesis in SK-N-SH cells. To 
attribute characteristics of 1716 to each of these two genes (ICP34.5 or ORF P), a number of HSV-1
recombinant viruses that express ICP34.5 and ORF P independently were constructed, purified and 
characterized. The parent of these recombinants is 1716 and they are (so called): 1622, expressing 
ICP34.5; 1624/24.5, expressing ORF P; and 1625, expressing both ICP34.5 and ORF P in separate loci. 
Using homologous recombination in cell culture, the recombinants were constructed and their DNA 
were analyzed by Southern-blotting. Expression of ICP34.5 and ORF P from the recombinants was 
checked by Western-blotting. Using cell culture, titration and plaque assay techniques, replication 
kinetics of the recombinants were compared with 17+ and 1716 in 3 cell lines, BHK, 3T6, and SK-N-
SH. The results showed that (i) ICP34.5 restored the ability to replicate and prevent host shutoff 
similar to wild type in SK-N-SH cells; (ii) ICP34.5 restored the replication phenotype to near wild type 
levels in 3T6 cells; and (iii) ORF P expression had no effect on the replication of these mutants. The 
characteristics of 1716 is obviously due to the lack of ICP34.5 and ORF P has no role in the 
characteristics studied. Thus, the function of ORF P still has to be determined.   Iran. Biomed. J. 9 (3): 95-
101, 2005
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INTRODUCTION
erpes simplex virus type-1 (HSV-1) is 
widely distributed in the human population 
and is the leading cause of acute sporadic 
viral encephalitis and viral induced blindness [1, 2]. 
HSV-1 is a neurotropic pathogen of humans that 
establishes a lifelong latent infection in the sensory 
ganglia innervating the site of primary infection. 
The capacity of the latent virus to reactivate is 
essential for its lifecycle and pathogenicity and a 
number of genes such as thymidine kinase are 
involved in virus pathogenicity and latency [3]. 
Several lines of evidence have mapped a 
neurovirulence locus to a gene, ICP34.5, in the long 
repeat region of the HSV-1 genome [4-8]. The 
ICP34.5 gene encodes a protein consisting of 263
amino acids with a Mr of 39 kDa in strain F [9, 10] 
and 248 amino acids with a Mr of 37 kDa in strain 
17+ [11, 12]. ICP34.5 is essential in vivo [7]. 
ICP34.5 null mutants are unable to replicate in the 
central nervous system of mice and are totally 
avirulent with a LD50 of 10
6 pfu/mouse higher than 
wild type or rescued virus [7, 8, 13]. In tissue 
culture, ICP34.5 null mutants replicate normally in 
many non-neuronal cell types such as Vero and 
BHK 21/C13 cells, but are restricted in SK-N-SH 
neuroblastoma and mouse embryo fibroblast (3T6) 
cells [7, 14-17]. In some non-permissive cells such 
as SK-N-SH, ICP34.5 null mutants induce a total 



































In 1994, Lagunoff and Roizman [18] 
demonstrated that there are 16 open reading frames 
(ORF A-P) located in the opposite direction to 
ICP34.5 within the latency associated transcript 
(LAT) in the long repeat sequences in strain F. One 
of these, ORF P, map almost entirely antisense to 
ICP34.5.  Detailed analyses of the products encoded 
by ORF P showed that ORF P expresses a 248-
amino-acid protein in strain F and a 233-amino-acid 
protein in strain 17+. To date, no definite roles have 
been attributed to ORF P except a possible role in 
splicing at early times of infection [18, 19]. 
A HSV-1 17+ spontaneous deletion mutant, 1716, 
which has a 759-bp deletion in the long repeat 
region, has been isolated and characterized [8]. In 
1716, both copies of ICP34.5 and ORF P in the 
inverted repeat sequences are deleted. This mutant 
showed major behavioural differences both in vivo
and in vitro compared to 17+. To assign the 
phenotypes of this mutant to either ICP34.5 or ORF 
P, a number of recombinant viruses based on 1716
were constructed. In these mutants, either only 
ICP34.5 or ORF P was inserted back into 1716 or 
both were inserted at separated loci and the 
phenotypes of these recombinants were analyzed. 
The recombinants are: 1622 expressing ICP34.5; 
1624 and 1624.5 expressing ORF P in opposite 
orientation; and 1625 expressing both ORF P and 
ICP34.5 in separate loci. The goal of this work was 
to investigate the role of both ICP34.5 and ORF P 
in HSV-1 replication in vitro. An approach to 
achieve this idea is construction and in vitro
characterization of a number of recombinants 
expressing these two genes.
MATERIALS AND METHODS
Cells.  Baby hamster kidney (BHK) cells were 
grown in Eagle’s medium (Life technology, UK) 
supplemented with 10% (v/v) newborn calf serum 
[20]. Human neuroblastoma (SK-N-SH) cells and 
mouse embryo fibroblast 3T6 cells (European 
Tissue Culture Collection) were grown in 
Dulbecco’s modified Eagle’s medium (Life 
Technology, UK) supplemented with 10% (v/v) 
FCS.
Viruses.  The wild type virus used was HSV-1
17+ [21]. The HSV-1 17+ deletion variant 1716 [8] 
was used as the parental virus for making 
recombinant viruses and as an ICP34.5 negative 
control in many experiments. 
Plasmids.  A number of plasmids used in this 
work were available in our Laboratory and are 
include: p35 ICP34.5, in which gD/ICP34.5 was 
(n.p 94711) inserted into the HSV-1 UL43.5 and 
LacZ in Ul43 orientation in p35 [22, 23]. This 
plasmid was digested with XbaI to generate a 
linearized fragment containing gD ICP34.5/LacZ 
with flanking HSV DNA and was recombined with 
1716 to generate 1622. p35/ORF P was constructed 
in the same manner as p35/ICP34.5. This plasmid 
was digested with XbaI to generate a linearized 
fragment containing gDORF P/LacZ with flanking 
HSV DNA and was recombined with 1716 to 
generate 1624.5. The same procedure was used to 
construct 1624. pAT5.1/gDORFP, which contains 
HSV-1 (n.p.136,289-139,258) US5 and gD/ORF P 
was cloned into the US5 plasmid. This plasmid was 
used to construct 1625. GST (Pharmacia, UK); 
GST-ORF P in which ORF P was inserted in frame 
at the end of GST.
Generation of anti-ORF P sera.  ORF P was 
expressed as a fusion protein using the pGEX GST 
system [24]. The GST fusion protein was expressed 
in protease-deficient E. coli BL21 (Stratagene) and 
GST-ORF P was purified as previously described 
[24]. Two New Zealand white rabbits were injected 
with 1 mg of fusion protein in complete Freund’s 
adjuvant, followed by three booster injections in 
incomplete Freund’s adjuvant at 14-day intervals, 
and subsequently the blood samples were collected.
Western-blotting.  Western-blotting was carried 
out essentially using anti-ICP34.5 [25] and anti-
ORF P sera as described by McKay et al. [12].
Southern-blotting.  Southern-blotting was carried 
out essentially as described by MacLean et al. [8]. 
Multicycle replication kinetics.  Multicycle 
replication kinetics in BHK, 3T6 and SK-N-SH 
cells were determined using a m.o.i of 0.001
pfu/cell as described by MacLean et al. [8]. 
Samples were harvested at the designated time 
points (usually 0, 6, 12, 24, 48, 72 and 96 h) and 
titrated on BHK cells. 
RESULTS
Construction of recombinant viruses.  All of the 
recombinant viruses used in this work have 1716 as 
their parent (Fig. 1a). The recombinant, 1622
expresses both gD/ICP34.5 and LacZ (Fig. 1b). To 
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Fig. 1. Structure of 1716, 1622, 1624.5 and 1625.  (a), This figure shows the structure of 1716. “a” is a direct repeat sequence 
present at both termini and in inverted orientation “a” in the internal repeat. “b” refers to the long and “c” to the short repeat. “X” 
indicates the deletion of ICP34.5/ORF P. The position of the NsiI site plus additional SpeI site in UL43/43.5 is shown; (b), This line 
shows the structure of 1622. ICP34.5/LacZ containing an internal BamHI site was inserted into UL43/43.5 with ICP34.5 in the 
UL43.5 and LacZ in the UL43 orientation. The arrowheads indicate the orientation of transcription; (c), This line shows the structure 
of 1624.5. gD/ORF P/LacZ containing an internal BamHI site was inserted into UL43/43.5 with gD/OFR P in the UL43.5 and LacZ 
in the UL43 orientation. The arrowheads indicate the orientation of transcription. The 1624 also has the same structure; (d), This line 
shows the structure of 1625. ICP34.5/LacZ containing an internal BamHI site was inserted into UL43/43.45 and gD/ORF P was 
inserted into US5. The arrowheads indicate the orientation of transcription.
linearized p35/ICP34.5. The recombinant, 1624.5
expresses both gD/ORFP and LacZ  (Fig. 1c). To 
construct 1624/1624.5, 1716 DNA was 
cotransfected with linearized p35/ORF P. 1625, 
whose parent is 1622, expresses both ICP34.5 and 
LacZ, and gD/ORF P being inserted into US5 (Fig. 
1d). To construct 1625, 1622 DNA was 
cotransfected with linearized pAT5.1/ORF P. 1622
and 1624.5 were originally purified on the basis of 
their blue plaque morphology in the presence of X-
gal and subsequently by their DNA profile, on 
Southern-blotting. The 1625, which has no 
additional colour marker, was isolated by its DNA 
profile, on Southern-blotting.
Expression of ICP34.5 and ORF P from 
recombinant viruses.  By Western-blotting of BHK 
cell extracts with an anti-ICP34.5 serum it was 
demonstrated that 1622 and 1625 express ICP34.5. 
Also, by Western-blotting of BHK cell extracts with 
an anti-ORF P serum, it was shown that 1624, 
1624.5 and 1625 express ORF P (data not shown).
Multicycle replication kinetics in BHK, 3T6 and 
SK-N-SH cells.  The aim of this part of work was to 
determine the effect of inserting ICP34.5 or ORF P 
back into 1716.
In BHK cells, 17+ and 1716 have been previously 
shown to grow identically [17]. Therefore as 
expected (Fig. 2), all viruses with the exception of 
1624 exhibited a similar growth pattern, reaching a 
maximum titre of 108-109 pfu/ml by 48-72 h pi. 
In the stationary state of 3T6 cells, as is shown in 
Figure 3, 17+ grew well reaching a maximum titre 
of 106-107 pfu/ml by 48-72 h pi whereas 1716, 
expressing neither ICP34.5 nor ORF P failed to 
grow. The recombinants 1624 and 1624.5 which 
express only ORF P, similarly to 1716, failed to 
grow whereas 1622 and 1625 expressing ICP34.5
grew. Both 1622 and 1625 grew well and they 
reached a maximum titre of 101 to 102 fold lower 
than 17+ (Fig. 2). However, in some experiments, 
both 1622 and 1625 grew similarly (Fig. 3a) 
whereas in others 1625 grew 10 fold less well than 
1622. Most consistently, 1625 grew to a maximum 
titre 10 fold lower than 1622 (Fig. 3b).
In SK-N-SH cells (Fig. 4), 17+ grew well reaching 
a maximum titre of 107-108 pfu/ml by 48-72 h pi. 


































Fig 2. Multicycle replication kinetics in BHK cells. BHK cells were infected at a m.o.i of 0.001 pfu/cell. At 0, 6, 12, 24, 48, 72, 
and 96 h pi, infected cells were harvested. Infected cells were scraped into the medium, sonicated and titrated onto a BHK 
monolayer. To obtain more reliable results, these experiments were carried out 2 times on each cell line. These separate experiments 
(a and b) are shown.
104 lower than 17+. In agreement with its impaired 
growth in BHK cells, 1624 grew consistently 10
fold poorer. Both 1622 and 1625 grew similarly to 
17+ (Fig. 4a). In some experiments, 1622 and 1625
grew similarly (Fig. 4a), whilst in others 1625 grew 
about 5 fold poorer than 1622 (Fig. 4 b).
DISCUSSION
The basic design of all recombinant viruses was the 
insertion of an expression cassette into the 1716
UL43/UL43.5 locus in the UL43.5 orientation. 
UL43/43.5 was selected as the site of insertion as 
both of them are non-essential genes [22]. In this 
cassette, the gene of interest was inserted under a 
HSV-1 gD promoter with a HSV-2 IE4/5
polyadenylation signal. In the opposite orientation, 
the lacZ gene was inserted under a SV40 promoter 
with its own polyadenylation signal. 1622 expresses 
gD/ICP34.5, 1624/1624.5 expresses gD/ORF P and 
1625 expresses gD/ICP34.5 and also gD/ORF P in 
the non-essential US5 gene [4, 26].  
Fig. 3. Multicycle replication kinetics in 3T6 cells.  The 3T6 cells were infecetd  at a m.o.i of 0.001 pfu/cell. At 0, 6, 12, 24, 48, 72, 
and 96 h pi infected cells were harvested. Infected cells were scrapted into the medium, sonicated and titrated onto a BHK 
monolayer. To obtain more reliable results, these experiments were carried out 2 times on each cell line. These separate experiments 
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Fig. 4. Multi-cycle replication kinetics in SK-N-SH cells.  SK-N-SH cells were infecetd at a m.o.i of 0.001 pfu/cell. At 0, 6, 12, 24, 
48,72, and 96 h pi infected cells were harvested. Infected cells were scraped into the medium, sonicated and titrated onto a BHK 
monolayer. To obtain more reliable results, these experiments were carried out 2 times on each cell line. These separate experiments 
(a and b) are shown.
Western-blotting analysis of 1622 and 1625
infected BHK cells demonstrated the expression of 
ICP34.5 in levels compared with wild type 17+. 
1624, 1624.5 and 1625 express low levels of ORF P 
protein. The antisera used were rabbit polyclonal 
sera which were raised against a GST-ORF P fusion 
protein. These antisera exhibited problems of low 
levels detection of ORF P from the recombinants
and to a lesser extent from 17+ but not from the 
overproducing ts mutant in ICP4 (tsK) at the non-
permissive temperature (NPT).
It had been previously shown that neither ICP34.5
nor ORF P is essential for replication of HSV-1 17+
in BHK cells [8]. Therefore, as expected in these 
cells, all the recombinant viruses, except 1624, had 
a similar growth pattern to wild type virus, 
confirming that the viruses had no secondary 
mutations effecting growth. The 1624 seems to be 
impaired in growth in BHK cells compared with the 
other viruses, indicating a probable secondary 
mutation elsewhere in the genome. 
In stationary state, 3T6 cells, 1624 and 1624.5
behaved similarly to 1716 and failed to grow 
whereas 1622 and 1625 grew. In this cell line, 
replication of ICP34.5 null mutant (1716) has been 
previously shown to be severely impaired compared 
to 17+ [16,17]. These workers also showed a similar 
result to this work, that in this non-permissive cells, 
the growth defect of ICP34.5 null mutants is 
greaterwhen they are in a stationary phase [17]. One 
explanation is that non-permissive cells infected 
with ICP34.5 null mutants undergo a total shutoff of 
protein synthesis. Thus, the defect in 1716 was 
mainly overcomed by the expression of ICP34.5 but 
not ORF P. Expression of ORF P either by itself or 
in conjunction with ICP34.5 had no positive effect 
on 1716 growth. 
The growth of 1716 in SK-N-SH cells had not 
been previously characterized. In SK-N-SH cells, 
17+ grew well reaching a maximum titre of 107-108
pfu/106 cells. It has been suggested that the role of 
ICP34.5 is to maintain host and viral protein 
synthesis late in some cell lines such as SK-N-SH 
by blocking the shutoff of host protein synthesis 
[15]. As expected, based on the host protein 
synthesis shutoff phenotype, SK-N-SH cells are 
fully not permissive for 1716. However, our results 
showed that this cell line is semi permissive for 
1716 exhibiting limited growth with a maximum 
titre of 104 fold lower than 17+. Two possibilities 
could explain this semi-permissive rather than non-
permissive phenotype. As SK-N-SH cells are a 
heterogenous cell line and a small percentage of 
cells have dedifferentiated and reverted to 
fibroblasts, these dedifferentiated cells might fully 
support 1716 replication whilst the differentiated 
cells are non-permissive. Alternatively, host protein 
synthesis shutoff might not completely inhibit 
growth of 1716 in infected SK-N-SH cells allowing 
limited growth of 1716 in these cells. The 1624.5
grew similarly to 1716 and thus expression of ORF 
P has no positive effect on 1716 growth. In 
agreement with its impaired growth in BHK cells, 
1624 grew consistently 10 fold poorer than 1716. 
Both 1622 and 1625 grew similarly to 17+ and thus 
expression of ICP34.5 restores 1716 growth to 17+
levels in SK-N-SH cells. It appears that the lack of 


































SK-N-SH cells is due to the lack of ICP34.5. 
Obviously, ORF P has no role on growth of this 
strain on these cell lines. Therefore, the function of 
ORF P still has to be determined.
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